Cique-Moya A.
Disponible en: http://www.emcdda.europa.eu/system/files/publications/
11364/20191724_TDAT19001ESN_PDF.pdf.
8. Department of Homeland Security. Protecting First Responders on the
Frontlines of the Fentanyl Epidemic. Proceedings from the 2017 Working
Meeting. Department of Homeland Security – Countering Weapons of Mass
Destruction – Office of Health Affairs. September 6-7, 2017. 01/05/18 (accedido
01/07/20). Disponible en: https://www.dhs.gov/sites/default/files/publications/
ochco-dhs-proceedings-from-fentanyl-working-meeting-20180501.pdf.
9. Cima G. Synthetic opioids put police dogs at risk. American Veterinary Medical
Association 18.01.18 (accedido 01/07/20). Disponible en: https://www.
avma.org/javma-news/2018-02-01/synthetic-opioids-put-police-dogs-risk.
10. Brown AJ, Mandell DC. Illicit drugs. En: Small Animal Critical Care Medicine.
Chapter 81. 2009: 342-345.
11. Nava-Mesa MO, Tellez-Arevalo A, Rojas-Kozhakin D, Calderón-Ospina CA.
Usos terapéuticos potenciales de los antagonistas opioides: fisiopatología y
evidencia preclínica. Rev. Colomb. Cienc. Quim. Farm. 2015; 44(3): 322-358.
12. Valdivielso Serna A. Dolor agudo, analgesia y sedación en el niño (IIIa): Farmacocinética
y farmacodinamia de los analgésicos opioides. Anales Españoles
de Pediatria 1998; 48(4): 429-440.
13. Junta de Andalucía. Definición y descripción de las propiedades de algunos
opiáceos y opioides. Consejería para la Igualdad y Bienestar social
(accedido 01/07/20). Disponible en: https://www.easp.es/pepsa/
estudios+y+documentos/monografiaopiodes.htm.
14. Muriel C, Santos J, Sánchez-Montero FJ. Farmacología de los analgésicos
opiáceos. Máster del dolor – módulo 7. Cátedra extraordinaria del Dolor
– Fundación Grunenthal (accedido 01/07/20). Disponible en: http://www.catedradeldolor.
com/PDFs/Cursos/Tema%207.pdf.
15. Schmiedt Chad W. Accidental prehension and suspected transmucosal or
oral absorption of fentanyl from a transdermal patch in a dog. Veterinary
Anaesthesia and Analgesia 2007; 34(1): 70-73 https://doi.org/10.1111/j.1467-
2995,2006,00302.x.
16. Bischoff K. Toxicity of drugs of abuse. En: Veterinary Toxicology, Edited by
Ramesh C. Gupta Academic Press 2007: 391-410.
17. Malouin A, Boller M. Sedatives, Muscle Relaxants, and Opioids Toxicity. En:
Small Animal Critical Care Medicine. Chapter 83. 2009: 350-356.
18. Khan Safdar A. Toxicities from Illicit and Abused Drugs (accedido 01/07/20).
Disponible en: https://www.msdvetmanual.com/toxicology/toxicities-fromhuman
drugs/toxicities-from-illicit-and-abused-drugs.
19. Agencia Española del Medicamento y de los Productos Sanitarios. Ficha
técnica Naloxona B. Braun 0,4 Mg/Ml solución inyectable y para perfusión.
Marzo 2018 (accedido 01/07/20). Disponible en: https://cima.aemps.es/cima/
pdfs/es/ft/69533/FT_69533.pdf.
20. Goldfrank, LR Weisman, RS. Opioids. En: Toxicologic Emergencies, Goldfrank,
LR, Flomenbaum, NE, Lewin, NA, Weisman, RS, Howland, MA
and Hoffman, RS (eds.), Appleton and Lange, Norwalk, C 1994: 847-862.
21. Poppenga RH. Illicit Drug Intoxications of Small Animals (accedido
01/07/20). Disponible en: https://www.vin.com/apputil/content/defaultadv1.
aspx?pId=11131&catId=29210&id=3844041.
22. Mieke Robertson T, Hendey Gregory W, Stroh G, Shal M. La administración
intranasal de naloxona es una alternativa viable a la administración intrevanosa
de naloxona en los pacientes con sobredosis de opiáceos atendidos en
el contexto prehospitalario. Prehospital EMergency CAre (Ed. Esp.), 2010;
3(1): 31-35.
23. College of Veterinary Medicine. Emergency Protocol: Canine Opioid Exposure
or Suspected Exposure. University of Illinois at Urbana-Champaing
14.03.17 (accedido 01/07/20). Disponible en: https://vetmed.illinois.edu/wpcontent/
uploads/2017/04/opioid-emergency-protocol.pdf.
24. Copland VS, Haskins SC,Patz J. Naloxone reversal of oxymorphone effects
in dogs Am J Vet Res.1989 Nov; 50(11): 1854-1858.
25. Gaynor JS. Intranasal Use of Naloxone in Working Canines. September
2016 http://usarveterinarygroup.org/usarvet/wp-content/uploads/2016/09/
Narcan_IN_for_Work_Dogs_OD.pdf.
44 Sanid. mil. 2021; 77 (1)
26. Khan Safdar A. Toxicities from Illicit and Abused Drugs. Aug 2014 (accedido
10.05.20). Disponible en: https://www.msdvetmanual.com/toxicology/
toxicities-from-human-drugs/toxicities-from-illicit-and-abused-drugs.
27. Lobo M, Díaz MJ, García J, Frejo MT. Estudio piloto sobre la prescripción
en situaciones excepcionales. Uso de medicamentos de humana en medicina
veterinaria. Clin. Vet. Peq. Anim, 2011; 31(3): 143-149.
28. Brice-Saddler M. Jake the narcotics dog went into a prison to sniff for drugs.
What he found killed him» The Washington Post (edición online) 23.07.19
(accedido 25.11.19). Disponible en: https://www.washingtonpost.com/science/
2019/07/23/jake-narcotics-k-died-after-sniffing-synthetic-weed-an-alabama
prison/.
29. Organización Mundial de la Salud. Manejo del abuso de sustancias -
Información sobre la sobredosis de opioides. noviembre de 2014 (accedido
01/07/20). Disponible en: https://www.who.int/substance_abuse/
information-sheet/es/.
30. Mitek A, McMichael M. Emergency Protocol: Canine Opioid Exposure
or Suspected Exposure Veterinary Medicine at Illinois 14.04.17 (accedido
30.06.20). Disponible en: https://vetmed.illinois.edu/wp-content/
uploads/2017/04/opioid-emergency-protocol.pdf.
31. College of Veterinary Medicine, Overdose in Working Dogs: Full Video
Script. University of Carolina at Urbana-Champaign 14.05.17 (Accedido
01/07/20). Disponible en: https://vetmed.illinois.edu/overdose-working-dogsscript/.
32. Ayuso E. Urgencias Toxicológicas 13.04.18 (Accedido 25/11/19). Disponible
en: http://www.colvema.org/WV_descargas/intoxicacionesAMVAC
13042007193146.pdf.
33. Daza MA, Ayuso E. Intoxicaciones más frecuentes en pequeños animales.
AVEPA, 2004: 24(4) 231-239.
34. Cique Moya A. Asistencia veterinaria en incidentes químicos» Profesión veterinaria
2018; 23(91): 76-88.
35. Alberta Health Services, Interim Guidance For First Responders: Opioid
Misuse. Emergency Medical Services 01/17 (accedido 01/07/20). Disponible
en: https://www.albertamfr.ca/data/documents/OPIOID_MISUSE_INTERIM_
GUIDANCE_v.3.0.pdf.
36. Loos D. Police Dogs at Risk: Symptoms and Treatment of Opioid Exposure
in Canine Officers 13.04.18 (Accedido 25/11/19). Disponible en: https://www.
lexipol.com/resources/blog/police-dogs-risk-symptoms-treatment-opioidexposure
canine-officers/.
37. Office of Health Affairs. Protecting First Responders on the Frontlines of the
Fentanyl Epidemic Proceedings from the 2017 Fentanyl Working Meeting.
Department of Homeland Security Countering Weapons of Mass Destruction
01.05.18 (accedido 01/07/20). Disponible en: https://www.dhs.gov/sites/
default/files/publications/ochco-dhs-proceedings-from-fentanyl-workingmeeting
20180501.pdf.
38. Seal K, Grobelna A. Personal protective equipment for health care workers
exposed to opioids: clinical effectiveness and guidelines. Ottawa: CADTH;
(CADTH rapid response report: reference list). 2017 Sep. 08/09/17 (accedido
01/07/20). Disponible en: https://cadth.ca/sites/default/files/pdf/htis/2017/
RA0926%20PPE%20for%20Opioid%20Exposure%20Final.pdf.
39. The Interagency Board. Recommendations on Selection and Use of Personal
Protective Equipment and Decontamination Products for First Responders
Against Exposure Hazards to Synthetic Opioids, Including Fentanyl and
Fentanyl Analogues 08/17 (accedido 01/07/20). Disponible en: https://www.
hsdl.org/?abstract&did=803191.
40. American College of Medical Toxicology, American Academy of Clinical
Toxicology
«ACMT and AACT Position Statement: Preventing Occupational
Fentanyl and Fentanyl Analog Exposure to Emergency Responders (Accedido
01/07/20). Disponible en: https://www.acmt.net/_Library/Positions/
Fentanyl_PPE_Emergency_Responders_.pdf.
41. 3M. Information to Help With Fentanyl Personal Protective Equipment
Selection
3M (Accedido 01/07/20). Disponible en: https://multimedia.3m.
com/mws/media/1458872O/fentanyl-white-paperus.pdf.